28/10/2019 : Theradiag and PredictImmune announce a strategic agreement French speaking Europe to commercialise PredictSURE IBD™, the world’s first validated prognostic test for inflammatory bowel disease
This exclusive deal with the French diagnostic specialist facilitates the first launch of PredictImmune’s prognostic tests in mainland Europe; and enables IBD patients in France, Belgium, Luxembourg and Switzerland to benefit from early prognosis. Cambridge,…